
Cartography Biosciences
@CartographyBio
Followers
419
Following
34
Media
74
Statuses
117
Building a smarter roadmap for precision therapeutics.
Joined November 2020
RT @BiocomCA: Our 2nd annual #ConvergeSummit will feature an engaging conversation between leaders from @CartographyBio, Genesis Therapeuti….
0
2
0
Cartography's CSO will join a panel discussion at the @BiocomCA Converge Summit to discuss how pharma collaborations can accelerate innovation. We look forward to an engaging conversation that dives deep into the power of partnerships in driving breakthrough advancements.
0
0
1
March is #ColorectalCancerAwarenessMonth, a time to amplify awareness & advance the conversation around CRC. We're pioneering CB21, a next-generation therapy designed for MSS CRC patients. Learn more from organizations like @CCAlliance and visit our website for our approach.
Not all cancer is pink. March is National Colorectal Cancer Awareness Month — blue is the color for colorectal cancer awareness 💙 Help us raise awareness by visiting #ColorectalCancerAwaressMonth #NotAllCancerIsPink
0
0
0
Cartography is attending @BioComCA Global Life Science Partnering & Investor Conference to connect with industry leaders & investors to map the future of #precisionmedicine. We look forward to engaging in discussions & collaborations that will shape the next frontier of biotech.
0
0
0
Cartography will be presenting at the upcoming @KeystoneSymp on February 19. This opportunity allows us to explore groundbreaking advances in antibody engineering & discuss identifying optimal targets and target pairs for pushing the boundaries of biologics towards precision.
0
0
0
On #IDWGS, we celebrate women transforming the way we tackle global challenges. From breaking stereotypes to mentoring the next generation, their contributions are shaping the future. We're proud to highlight the stories & wisdom of the #womeninscience at Cartography.
0
1
1
Cancer is the 2nd-leading cause of death worldwide, yet every patient's journey is unique. On World Cancer Day, we reaffirm our commitment to advancing #immunotherpaies & designing safer, more effective therapies that will have the greatest impact on those living with #cancer.
0
0
0
Another successful #JPM25! We're advancing cancer care with our ATLAS & SUMMIT platforms, powered by a fully integrated single-cell dataset to target & develop impactful therapies. Explore our pipeline & lead preclinical program:
0
0
1
We're honored to share the appointment of four distinguished experts to Cartography's Clinical Advisory Board. Their experience will be invaluable as we advance our lead asset, CB21 in #colorectalcancer, for an IND application and enhance our pipeline.
0
0
1
As we celebrate our 4th anniversary, we want to recognize the contributions of our team & founders, Howard Chang, Ansu Satpathy, & Kevin Parker, for their vision to transform #immunotherapy & #cancer treatment. We're grateful for their foundation & trust as we shape the future!
0
0
1
We had a productive day in Houston at the 39th Annual Meeting of #SITC24 last week, engaging with industry experts and presenting #preclinical data on LY6G6D. We appreciate everyone who visited our poster to learn more about our efforts toward advancing CB21 for MSS CRC patients.
0
1
7
We're proud to share that @BiocomCA has honored our CEO with the 2024 Life Science Catalyst Award. This recognition is a testament to his exceptional leadership and the groundbreaking work he has spearheaded at Cartography. Congrats, Kevin, on this well-deserved recognition!.
We are excited to announce the winners of our 9th annual Life Science Catalyst Awards! These rising stars under 40 are driving innovation in life science in California. See this year’s winners:
0
0
2
CEO Kevin Parker, Ph.D., shared insight into our precision approach to #cancer, our new partnership with @GileadSciences and what's next for Cartography in the latest episode of the BIOS Builders podcast! Listen below. ⤵️.
🧱 Builders: Kevin Parker - President & CEO, Founder @ Cartography. @krparker of @CartographyBio on the future of #biotech: envisioning a world where cancer treatment is as precise as GPS. Discover how their antigen atlas is mapping the way. Tune in:
0
1
2
Take a listen: Our CEO Kevin Parker, Ph.D., shares how our newest collaboration with @GileadSciences is bringing us one step closer to shaping cancer #immunotherapy for those with triple-negative #breastcancer and adenocarcinoma.
0
3
6
We're thrilled to announce our strategic collaboration with @GileadSciences to discover and develop therapies for patients with triple-negative #breastcancer and the most common form of non-small cell #lungcancer, adenocarcinoma. Learn more:
0
2
9